US 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11932692 (Methods of treating cancer pain by administering a PD-1 inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/39558, A61P